Objectives
- Aligning Machine Learning groups across all SIGs.
- For clinical research statisticians, where specifically are AI & ML useful – considering regulatory requirements, and where are they not useful?
- Webinars to deliver this knowledge back to industry colleagues.
Upcoming Events
No events planned currently, we are looking into webinars for the future.
Achievements!
Here are our latest achievements:
- Submitted comments to the FDA on the latest AI guidance with a large contribution from the data science SIG - 2025
- Delivered a session on AI and machine learning at the 2025 PSI conference.
- Delivered a session on AI and machine learning at the 2026 PSI conference.
Topics of interest 2026
- Using AI for HTA
- Document Generation
- Shell to output TFL generation using AI
- What can AI not do
- AI tools for programming
- R tools for machine learning
AI & ML Blog
Sam Hadlington, Chair of the AI & ML SIG, has started a monthly blog to broaden the discussion around developments within AI. This could be on anything from an event recently appearing in the news or a reflection on something that may come to affect us in the future. We hope you enjoy reading, if you have any comments or thoughts please contact sam.hadlington@plus-project.co.uk.
Click below to read the blog.
AI Security - September 2026
How to get in touch
Interested in joining the AI & ML SIG?
Please send an email to the SIG chair and AI lead - Sam (sam.hadlington@plus-project.co.uk; LinkedIn)
Or
to the Machine Learning lead – Harry (harry.g.parr@gsk.com; Harry Parr | LinkedIn)
Who we are (as of June 2026)
The artificial intelligence and machine learning SIG is led by Sam Hadlington.
The full list of members of the AI & ML SIG can be found below:
| Name | Company/Institution |
|---|
| Augustin Thepaut | Roche |
| Conan Liang |
|
| Danila Azzolina | University of Ferrara |
| Dagoberto Ramos Pérez | Italfarmaco |
| Eliana Garcia Cossio | Bayer |
| Emmanuel Pham | Nova In Silico |
| Fabio Rigat | AstraZeneca |
| Frauke Hennig | Bayer |
| Harry Parr | GSK |
| Ilaria Piergentili | Valos |
| Jason Nicholas | GSK |
| Joshua Havumaki | GSK |
| Karl Koechert | Bayer |
| Kerry Hyland | Jazz Pharmaceuticals |
| Laura Belton | Consultant |
| Lesedi Ledwaba-Chapman | MMS Holdings |
| Matthew Norris | University of Leeds |
| Nicola Hewson | AstraZeneca |
| Nils Ternes | Sanofi |
| Paola Berchialla | University of Turin |
| Sam Hadlington | Plus-Project Partnership |
| Sarah Serahati | ICON |
| Susanne Schmitt | VRTX |
| Thomas Henderson | Amgen |
| Tommaso Panni | Eli Lilly |
| Verena Leonie | BioNTech |
| Wei Quan | AstraZeneca |
| Xiang Zhang |
|